跳至主要内容
临床试验/CTRI/2025/04/084042
CTRI/2025/04/084042尚未招募不适用

A CLINICO-PATHOLOGICAL STUDY OF HERBO-MINERAL COMPOUND WITH STANDARD CARE ON SICKLE CELL ANEMIA

Dusmanta Kumar Majhi1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年4月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
Decrease in Symptoms like Panduta, Durvalata, Sadana, Angamarda, Jwara, Swasa, Aruchi, Gourava, Chhardi, Mala-mutra & Netraswetata

研究概览

简要总结

This is a Clinco-Pathological study of Herbo-Mineral Compound with Standard Care on Sickle cell Anemia. This is done Compulsory part of Ph.D Course. Total Number  of patients to be studied is 70 with duration of 90 Days.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
12.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • 1.12 years of age up to 50 years, Both sexes
  • Homozygous sickle cell disease (HbSS)
  • Having Clinical Sign and Symptoms of SCD.
  • Willing to adhere to study procedures and to give written informed consent.

排除标准

  • Age less than 12 years and more than 50 years
  • Heterozygous sickle cell disease (HbAS)
  • Chronic illness and pain disorders (leg ulcers, fever, fractures causing pain)
  • Pregnant, lactating mother, planning pregnancy,
  • Transfusion within 3 weeks and any other Grievous causes.
  • Refusal to provide access to relevant medical records/Consent.

结局指标

主要结局

Decrease in Symptoms like Panduta, Durvalata, Sadana, Angamarda, Jwara, Swasa, Aruchi, Gourava, Chhardi, Mala-mutra & Netraswetata

时间窗: Decrease in Symptoms like Panduta, Durvalata, Sadana, Angamarda, Jwara, Swasa, Aruchi, Gourava, Chhardi, Mala-mutra & Netraswetata

次要结局

  • Herbo-Mineral Compound is more effective than Hydroxyurea(91 Days)

研究者

发起方
Dusmanta Kumar Majhi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dusmanta Kumar Majhi

Sri Sri College of Ayurvedic Science and Research Hospital Sri Sri University Cuttack

研究点 (1)

Loading locations...

相似试验